Lydimycin
Lydimycin (α-DHB; α-Dehydrobiotin) is an antibiotic produced by Streptomyces lydicus, with antibacterial, antifungal and antiviral activities. Lydimycin inhibits the binding of SARS-CoV-2 S-614G spike protein to human ACE2. The antibacterial activity of Lydimycin can be reversed by Biotin (HY-B0511) in the culture medium. Lydimycin is applicable to infection-related research.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 10118-85-1
- 分子式: C10H14N2O3S
- 分子量:242.29
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
Antibiotic アイソフォーム固有の製品をすべて表示
More
生物活性
製品説明
IC50 & Target
Bacterial[1]
体外実験
Lydimycin (compound Ⅰ) displays broad-spectrum in vitro antimicrobial activity against diverse gram-positive bacteria, gram-negative bacteria, and fungi[1].
Lydimycin (1.25-20.0 μg) inhibits Escherichia coli growth in a synthetic medium in a dose-dependent manner, with its antibacterial activity reversed by increasing concentrations of biotin, showing no inhibition at 0.100 μg/mL Biotin (HY-B0511) across all tested doses[1].
Lydimycin (0-200 μM) inhibits the binding of SARS-CoV-2 S-614G-Strep spike protein to human ACE2-Fc with an IC50 of 1.6 μM, without non-specific Alpha signal interference[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 10118-85-1
-
分子量 242.29
-
分子式 C10H14N2O3S
-
SMILES
C(C/C=C/C(O)=O)[C@H]1[C@@]2([C@@](NC(=O)N2)(CS1)[H])[H]
-
別名
α-DHB; α-Dehydrobiotin
-
Structure Classification
-
Initial Source
Streptomyces lydicus
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)